Gene Query: RALGAPA1

Dataset Description Geneva Score
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 36.3
Knockdown of ADNP in HCT116 colon cancer cells 29.4
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 28.04
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 26.7
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 26.55
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 25.93
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 25.04
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 20.77
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 19.53
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 19.53
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 19.49
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 18.41
Studying the selectivity of a small molecule Synucleozid on transcriptome 17.55
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 17.2
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 16.79
Differential expression of genes in AD169-infected MRC5. 16.56
Genome wide expression change in LCC2 and MCF-7 cells 16.32
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 16.28
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 16.28
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 16.1
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 15.87
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 15.84
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 15.78
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 15.78
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 15.71
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 15.69
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 15.51
Evolution of a transcriptional regulator from a transmembrane nucleoporin 15.35
RNA-seq in HepG2 and IMR90 cells 15.35
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 15.34
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 15.07
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 14.74
TGF-β regulation of miRNA expression in pancreatic cancer 14.6
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 14.47
Total RNA-seq in ALL-SIL upon JQ1 inhibition 14.35
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 14.26
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 13.66
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 13.29
Gene expression profiling of leukemia cells following asparagine depletion 13.06
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 12.9
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 12.84
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 12.84
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 12.61
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 12.57
The regulartory role of ZCCHC24 in splicing machinery 12.56
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 12.28
Human cell line and subcutaneous tumor 12.11
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 12.1
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 12.09
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 12.09
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 11.82
Impact of dieldrin on transcription in Jurkat T cells 11.8
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 11.75
High-throughput sequencing of PROMPT-enriched samples. 11.72
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 11.65
Effect of CHKA knockdown on C4-2 cell transcriptome 11.49
Global Mapping of Human RNA-RNA Interactions 11.39
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 11.29
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 10.83
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 10.6
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 10.56
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 10.55
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 10.45
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 10.45
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 10.41
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 10.22
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 10.17
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 10.09
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 9.82
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 9.79
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 9.78
Region-specific Innate Antiviral Responses of the Human Epididymis 9.72
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 9.72
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 9.62
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 9.3
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 9.3
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 9.3
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 9.2
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 9.2
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 9.17
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 9.17
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 9.14
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 9.11
Examining serotonergic neuron differentiation from human iPSCs 9.1
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 9.1
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 8.86
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 8.75
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 8.75
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 8.73
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 8.73
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 8.72
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 8.72
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 8.71
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 8.7
The transcriptome effect of overexpressing EZH2 in MCF7 8.66
Primate transcript and protein expression levels evolve under compensatory selection pressures 8.61
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 8.57
Gene expression changes caused by KRAS in MCF-10A 8.56
BCL11B 8.56
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 8.55
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 8.53
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 8.53
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 8.47
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 8.44
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 8.44
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 8.42
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 8.41
RNAseq Study in CC-671 Treated Cal-51 Cells 8.4
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 8.27
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 8.17
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 8.16
Single-nucleotide-resolution mapping of HBV promoters using CAGE 8.12
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 8.11
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 8.11
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 8.01
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 7.91
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 7.91
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 7.9
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 7.9
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 7.87
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 7.87
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 7.79
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 7.79
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 7.78
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 7.75
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 7.75
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 7.75
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 7.74
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 7.72
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 7.65
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 7.62
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 7.61
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 7.61
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 7.6
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 7.6
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 7.54
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 7.43
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 7.36
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 7.36
The contribution of Alu exons to the human proteome 7.35
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 7.25
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 7.24
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 7.21
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 7.17
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 7.16
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 7.16
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 7.14
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 7.14
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 7.09
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 7.09
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 7.09
The age and genomic integrity of neurons after cortical stroke in humans 7.07
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 7.06
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 7.03
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 7.01
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 6.99
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 6.99
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 6.95
Nutritional control of protein translation 6.94
R430: A potent inbibitor of DNA and RNA viruses 6.94
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 6.93
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 6.9
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 6.89
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 6.86
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 6.84
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 6.83
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 6.8
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 6.8
RNA-seq in transgenic cells 6.78
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 6.75
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 6.68
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 6.65
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 6.61
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 6.56
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 6.55
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 6.55
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 6.55
Genome-wide functional assessment of enhancer activities in the human genome 6.53
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 6.39
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 6.38
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 6.38
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 6.36
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 6.34
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 6.28
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 6.27
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 6.27
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 6.25
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 6.22
RNA sequencing of mechanically strained NHEKs and control NHEKs 6.2
Short and Long RNA sequencing of human mature erythrocytes 6.17
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 6.16
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 6.16
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 6.13
Transcriptome analysis of U87 cells upon LINC00152 knockdown 6.11
RNA-Sequencing of HepG2 cells treated with TGFBeta 6.11
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 6.11
Differentially expressed genes post knock down of lincDUSP26 6.09
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 6.09
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 6.08
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 6.05
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 6.05
MYCL and EP400 are required for Max and MCPyV mediated gene activation 5.99
RNA seq comparison between scrambled and shGRP78 cells 5.99
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 5.98
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 5.98
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 5.97
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 5.97
circRNA-sequencing 5.96
Transcriptome of Stabilin-1 siRNA transfected human monocytes 5.95
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 5.93
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 5.92
Transciptomic profiling of human fetal lung samples 5.87
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 5.86
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 5.86
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 5.77
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 5.76
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 5.76
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 5.72
Effect of PBK knockdown on C4-2 cell transcriptome 5.72
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 5.71
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 5.71
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 5.65
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 5.61
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 5.6
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 5.57
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 5.57
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 5.53
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 5.51
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 5.5
ARID1A and ARID1B loss in HCT116 and TOV21G cells 5.49
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 5.49
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 5.49
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 5.45
Transcriptomic profiling of human peripheral blood-derived mast cells 5.45
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 5.45
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 5.35
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 5.3
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 5.3
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 5.29
Loss of CREBBP results in gene expression repression in lymphoma cells 5.27
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 5.27
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 5.27
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 5.27
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 5.26
Transcriptional profiles of normal human mature B cells 5.25
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 5.23
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 5.23
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 5.19
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 5.16
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 5.16
UBC9 knockdown in bladder cancer T24 cell lines 5.16
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 5.12
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 5.12
Depicting early human development and germ cell origin with porcine embryos 5.11
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 5.11
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 5.1
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 5.1
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 5.09
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 5.08
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 5.01
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 4.98
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 4.96
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 4.94
Microprocessor mediates transcription termination in long noncoding microRNA genes 4.94
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 4.91
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 4.91
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 4.91
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 4.89
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 4.85
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 4.84
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 4.82
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 4.8
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 4.8
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 4.78
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 4.78
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 4.77
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 4.72
RNA-sequencing of formalin fixed human primary melanoma tissue 4.66
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 4.65
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 4.65
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 4.62
Novel Targeting of Transcription and Metabolism in Glioblastoma 4.61
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 4.56
CHCHD10 gene KO effect in iPSC drived motor neurons 4.5
Epigenetic reprogramming of melanoma cells by vitamin C treatment 4.48
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 4.47
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 4.46
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 4.44
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 4.39
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 4.39
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 4.37
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 4.33
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 4.33
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 4.32
Oncogenic MYC induces a dependency on the spliceosome in human cancer 4.3
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 4.24
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 4.23
Endothelial gene expression analysis 4.23
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 4.16
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 4.15
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 4.1
Human Treg IL-12 stimulation 4.09
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 4.09
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 4.05
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 4.03
Regulation of poly(A) tail and translation during the somatic cell cycle 4.01
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 4.0
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 3.99
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 3.98
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 3.92
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 3.88
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 3.87
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 3.87
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 3.86
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 3.79
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 3.74
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 3.71
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 3.68
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 3.63
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 3.62
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 3.6
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 3.44
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 3.4
mRNA expression profile of Lymphocytes by high-throuput sequencing 3.32
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 3.23
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 3.08
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 3.08
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 3.08
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 3.04
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 3.02
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 3.0
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 3.0
Role of COP1 on MAP kinase transcriptional output in melanoma 3.0
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 3.0
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 3.0
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 2.98
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 2.95
Recovery and analysis of nascent RNA 2.93
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 2.93
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 2.91
BASP1 modifies the Tamoxifen response 2.9
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 2.86
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 2.8
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 2.8
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 2.78
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 2.78
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 2.77
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 2.76
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 2.74
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 2.74
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  2.73
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 2.65
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 2.64
Gene expression analysis of human hepatocellular cancers 2.59
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 2.57
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 2.57
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 2.5
RNAseq of cell lines with knocked in ESR1 mutations 2.48
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 2.45
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 2.43
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 2.41
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 2.4
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 2.4
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 2.39
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.38
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.38
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 2.37
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 2.36
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 2.34
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 2.28
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 2.27
mRNA-Seq profiling of human developing kidney 2.27
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 2.26
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 2.26
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.21
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 2.18
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 2.18
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 2.15
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 2.15
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 2.1
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 2.1
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 2.08
Gene expression analysis of human adenomas. 2.06
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 2.06
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.97
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 1.97
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 1.96
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 1.95
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 1.92
Dermal endothelial cells of type 2 diabetic patients 1.9
LINE-2 transposable elements are a source of functional human microRNAs and target sites 1.89
Conservative alteration of chromosomal expression pattern across human solid tumor types 1.85
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.84
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 1.8
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.78
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.78
Transcriptome analysis upon C6orf203 silencing 1.74
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.72
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 1.71
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 1.66
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 1.64
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.64
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.64
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.64
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.56
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 1.55
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.54
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 1.51
Gene profiling of human adult and pediatric liver cancer cells 1.51
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 1.5
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 1.46
Transcriptome-wide response to synthetic chromatin protein PcTF 1.45
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 1.43
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 1.41
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 1.38
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 1.38
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.38
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 1.37
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 1.34
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 1.33
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 1.29
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 1.29
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 1.29
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.29
Gene expression analysis in response to hypoxic pathway inhibition 1.25
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 1.24
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.21
The circadian transcriptional landscape in primary human mammary epithelial cells 1.18
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.17
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 1.14
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 1.13
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 1.03
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 1.03
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 1.02
Identification of long noncoding RNAs regulated by p53 1.01
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.01
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 1.0
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 1.0
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 0.98
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.97
quanTIseq: quantifying immune contexture of human tumors 0.97
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.96
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.94
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.94
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 0.91
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 0.89
Fibroblasts in cholesteatoma activate osteoclasts. 0.87
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 0.81
Gene expression regulated by CSA and CSB in neuroblastoma cell line 0.81
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 0.8
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 0.79
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 0.72
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 0.72
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 0.71
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 0.69
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 0.69
MCF-7 as a model for functional analysis of breast cancer risk variants 0.66
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 0.65
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.63
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.61
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 0.56
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.55
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.55
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 0.54
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 0.54
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.52
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.52
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 0.52
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.51
Preclinical model of obesity and ER-positive breast cancer 0.5
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.49
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.49
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.48
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 0.47
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.44
Ribosomal protein RPL26 is the principal target of UFMylation 0.43
Transcriptomes in healthy and CHB fetal hearts 0.42
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.36
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.36
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.35
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.32
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.26
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 0.15
Aging-associated patterns in the expression of human endogenous retroviruses 0.15
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 0.15
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.14
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.09
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.09
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.09
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.09
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.07
Modulation of nonsense-mediated decay by rapamycin 0.05
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 0.04
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 0.03
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.03
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 0.03
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.03
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.03
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 0.02
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation